LBP-16-Phase II trial to evaluate immunogenicity and safety of a new adjuvanted HBAI20 Hepatitis B vaccine in non-responders: BE RESPONDER.
| Autor: | Koc, Özgür, Smedt, Philippe de, Robaeys, Geert, Damme, Pierre Van, Almeida, Jorge, Falkenberg, Frank, Savelkoul, Paul H.M., Lashof, Astrid Oude |
|---|---|
| Zdroj: | In Journal of Hepatology April 2019 70(1) Supplement:e149-e149 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect